Mesirow Financial Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
MGP
Mesirow Financial Investment Management's BMY Position: Q2 2026 in Review
Mesirow Financial Investment Management increased its Bristol-Myers Squibb (BMY) stake by 33% in Q2 2026, buying an estimated $458K and bringing the position to 32,023 shares worth $1.85M. The position accounts for 0.03% of the portfolio, ranked #215.
Mesirow Financial Investment Management first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.78M in Q1 2025. 1,501 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Mesirow Financial Investment Management held 32,023 shares of Bristol-Myers Squibb worth $1.85M as of Q2 2026.
- Mesirow Financial Investment Management bought 7,973 Bristol-Myers Squibb shares in Q2 2026, an estimated $458K.
- Bristol-Myers Squibb made up 0.03% of Mesirow Financial Investment Management's portfolio in Q2 2026, its #215 holding.
- Mesirow Financial Investment Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
- Mesirow Financial Investment Management's Bristol-Myers Squibb position peaked at $2.78M in Q1 2025.
- 1,501 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Mesirow Financial Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.